Gilead Sciences, Inc.

Gilead’s vision is to create a healthier world for all people and we pursue initiatives that help improve global health equity. It is our joint responsibility to create ways in which access to care and treatment can be achieved globally in partnership with governments, civil society and communities we serve.
Since 1987, Gilead has commercialized more than 25 innovative medicines, helping to transform treatment for people living with diseases such as HIV, viral hepatitis, COVID-19, neglected tropical diseases and cryptococcal meningitis around the world. More importantly, we aim for our contribution to go beyond medicines: our goal is to eliminate diseases and deliver meaningful impact backed up by rigorous assessment.